The	tempest	beyond	the	test	tube	involves	allegations	that	the	U.S.	Food	and	Drug	Administration	violated	the	Orphan	Drug	law	by	allowing	Biogen	the	right	to	sell	its	multiple	sclerosis	drug	Avonex	.